HUT63848A - Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients - Google Patents

Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients Download PDF

Info

Publication number
HUT63848A
HUT63848A HU922540A HU254092A HUT63848A HU T63848 A HUT63848 A HU T63848A HU 922540 A HU922540 A HU 922540A HU 254092 A HU254092 A HU 254092A HU T63848 A HUT63848 A HU T63848A
Authority
HU
Hungary
Prior art keywords
formula
hydrogen
pyrazol
compounds
trifluoromethyl
Prior art date
Application number
HU922540A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9202540D0 (en
Inventor
Roger Bernard Titman
Michael Henry Hockley
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of HU9202540D0 publication Critical patent/HU9202540D0/hu
Publication of HUT63848A publication Critical patent/HUT63848A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
HU922540A 1990-02-06 1991-01-26 Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients HUT63848A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909002423A GB9002423D0 (en) 1990-02-06 1990-02-06 Therapeutic agents

Publications (2)

Publication Number Publication Date
HU9202540D0 HU9202540D0 (en) 1992-10-28
HUT63848A true HUT63848A (en) 1993-10-28

Family

ID=10670368

Family Applications (1)

Application Number Title Priority Date Filing Date
HU922540A HUT63848A (en) 1990-02-06 1991-01-26 Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients

Country Status (16)

Country Link
JP (1) JPH05504141A (ja)
KR (1) KR927003600A (ja)
AU (1) AU7187791A (ja)
BR (1) BR9105990A (ja)
CA (1) CA2074816A1 (ja)
FI (1) FI923528A0 (ja)
GB (1) GB9002423D0 (ja)
HU (1) HUT63848A (ja)
IE (1) IE910287A1 (ja)
IL (1) IL97109A0 (ja)
IN (1) IN172129B (ja)
MX (1) MX24407A (ja)
NO (1) NO923082L (ja)
PT (1) PT96687A (ja)
WO (1) WO1991012255A1 (ja)
ZA (1) ZA91833B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116241D0 (en) * 1991-07-27 1991-09-11 Boots Co Plc Therapeutic agents
US7081456B2 (en) * 2002-11-22 2006-07-25 Active Biotech Ab Immunomodulatory compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
NO923082D0 (no) 1992-08-05
ZA91833B (en) 1991-10-30
FI923528A (fi) 1992-08-05
BR9105990A (pt) 1992-11-10
WO1991012255A1 (en) 1991-08-22
IN172129B (ja) 1993-04-10
HU9202540D0 (en) 1992-10-28
AU7187791A (en) 1991-09-03
MX24407A (es) 1993-10-01
PT96687A (pt) 1991-10-31
CA2074816A1 (en) 1991-08-07
GB9002423D0 (en) 1990-04-04
FI923528A0 (fi) 1992-08-05
IE910287A1 (en) 1991-08-14
NO923082L (no) 1992-08-05
JPH05504141A (ja) 1993-07-01
KR927003600A (ko) 1992-12-18
IL97109A0 (en) 1992-03-29

Similar Documents

Publication Publication Date Title
EP1206467B1 (en) N-heterocyclic derivatives as nos inhibitors
TWI449696B (zh) 以５員雜環為主之ｐ３８激酶抑制劑
KR880001374B1 (ko) 항우울증 치료제인 2-펜옥시알킬-1,2,4-트리아졸-3-온 및 그의 제조방법
KR0171598B1 (ko) 부신피질자극호르몬 유리인자(crf) 길항 활성을 가지는 아미노-치환된 피라졸
CH664152A5 (fr) Derives de tetrahydrocarbazolones.
US5436247A (en) Quinoline or quinazoline derivatives, their production and use
JPH07324076A (ja) 新規なピラゾール−３−カルボキサミド誘導体、これらを製造するための方法及びこれらが存在する薬学的組成物
EP0417653A1 (en) 3-(1-Substituted-4-piperazinyl)-1H-indazoles, a process for their preparation and their use as medicaments
JP2007523139A (ja) 治療薬
JP2001512118A (ja) オキシドスクアレン−シクラーゼを阻害するピリジル−およびピリミジル複素環式化合物
EP0116769B1 (en) Dihydropyridines
HUT64523A (en) Process for producing 3-substituted-1-(aryl- or aryl-alkyl)-2(1h)-quinolones and medical preparatives containing them
RU1838299C (ru) Способ получени производных пиперидина или их солей с кислотами
WO2005121152A1 (en) Substituted triazole derivatives as oxytocin antagonists
FR2465732A1 (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique
HU196989B (en) Process for producing quinoline derivatives and pharmaceuticals comprising same
EP0107619B1 (en) Dihydropyrazolo(3,4-b)pyridine derivatives and production thereof
JPH05246980A (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
JP2008285481A (ja) 医薬組成物
JP2008024693A (ja) ピラゾール化合物
HUT63848A (en) Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients
EP0314363A2 (en) Anti-anxiety agents
JPH08508031A (ja) ５‐ｈｔ１ａリガンドとしてのアミド誘導体
US4395409A (en) Carbamoyloxyamino-1,4-benzodiazepines and medicaments containing these compounds
JPH0753546A (ja) ジアリール置換複素環化合物およびその医薬用途

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment
DFC4 Cancellation of temporary protection due to refusal